Health Observance

More than ‘just a headache’

June is Migraine Awareness Month
Vaishnavi Muralikrishnan
June 1, 2022

Most of us get headaches. Sure, it can be inconvenient, but you pop on a pain reliever and you’re fine within a few hours. 

But have you or your loved ones experienced debilitating headaches that make it impossible to carry on with normal activities? What you might be experiencing or hearing about is “migraine” or “cluster headaches.” 

Migraine is not just a headache. It is a neurological disorder, and headache is a primary symptom. 

According to the National Headache Foundation, 40 million Americans suffer from migraine. World Health Organization statistics state that one in seven adults worldwide has migraines, and the experience is three times more common in women than in men. 

How do you know if your headache is a migraine? 

You can use the ID Migraine Tool by the National Headache Foundation. 

  • Has a headache limited your activities for a day or more in the past three months?

  • Are you nauseated or sick to your stomach when you have a headache?

  • Does light bother you when you have a headache? 

Answering “yes” to two out of three of these simple questions effectively identifies migraine sufferers. 

What is a migraine, and what causes it? 

According to the Centers for Disease Control and Prevention, migraine is a complex neurological disorder. It often begins at puberty and mostly affects those people between the ages of 35 and 45. 

It is more common in women, usually by a ratio of about 2:1, because of hormonal influences. 

It is caused by the activation of a mechanism deep in the brain that leads to release of pain-producing inflammatory substances around the nerves and blood vessels of the head. 

Stages of migraine 

Migraine is complex and often occurs in different phases. According to Mayo Clinic, migraine can progress through four stages: prodrome, aura, attack and postdrome. It is important to note that the symptoms may not look exactly the same in everyone suffering from a migraine. 

Prodrome — A few hours to few days before an actual migraine attack, one might start to experience some warning signs such as: 

  • constipation

  • fluid retention

  • mood changes, from depression to euphoria

  • frequent yawning

  • increased urination

  • food cravings

Aura — The stage that follows the prodrome is the aura. According to Migraine Australia, about one-third of people with migraine experience an aura. 

Auras could include the following symptoms: 

  • visual phenomena, such as seeing various shapes, bright spots or flashes of light

  • vision loss

  • pins and needles sensations in an arm or leg

  • weakness or numbness in the face or one side of the body

  • difficulty speaking

Attack — An actual migraine attack can last anywhere between four hours to three days if left untreated. The frequency of attacks varies from one individual to another. 

Symptoms during a migraine attack may include:  

  • pain usually on one side of your head, but often on both sides

  • pain that throbs or pulses

  • sensitivity to light, sound, and sometimes smell and touch

  • nausea and vomiting

Postdrome —This phase is also referred to as a migraine hangover. After a migraine attack, one might feel exhausted and confused for up to a day. Some people report feeling euphoric.

Stigma associated with migraine 

Migraine is often misinterpreted as just a headache. This undermines the complexity of the disease, which is a genetic, neurological disorder with dozens of unique symptoms.

According to the CDC, more than 70% of people will experience a tension headache in their lifetime; however, not all these headaches may be a sign of migraine.

Organizations such as the National Headache Foundation are playing a pivotal role in creating awareness about migraine.

Diagnosis and treatment 

A neurologist should be able to diagnose a migraine based on physical examinations as well as by symptoms and medical history. In complex cases, one might need an MRI or a CT scan to identify the root cause of headaches, such as a tumor or brain damage.

Treatment for migraine mainly includes over-the-counter pain relievers as well as prescription medication such as Lasmiditan, Ubrogepant or opioid-based drugs.

Recent migraine research 

Check out the following articles about migraine published in the American Society for Biochemistry and Molecular Biology’s open-access journals. 

Identifying novel mechanisms involved in migraine development: The membranes of nerve cells contain voltage-gated calcium channels. It is known that mutations in the gene that encodes the α1-subunits of the Cav2.1 (P/Q-type) channels cause human diseases, including familial hemiplegic migraine type-1. In a study published in the Journal of Biological Chemistry, researchers examined how mutations in the β-subunits might also disrupt the functioning of calcium channels. They found that the mutations have profound effects.  

Relationship between migraine and opioid-induced pain hyper-sensitivity: Opioid-based treatment is commonly used to treat migraine. However, continued use of opioid substances can result in increased pain sensitivity known as opioid-induced hyperalgesia. A recent study published in the journal Molecular & Cellular Proteomics screened for changes in more than 1,500 neuropeptides under these two conditions. Using liquid chromatography-mass spectrometry, the researchers identified 16 neuropeptides that were altered between the two conditions. Of those, pituitary adenylate cyclase-activating polypeptide (known as PACAP for short) was confirmed to act as a link between chronic migraine and opioid-induced hyperalgesia.

Involvement of a cell membrane protein in hemiplegic migraine: Hemiplegic migraine is a rare and serious type of migraine headache that affects one side of the body, resembling a stroke. Scientists have identified a mutation in the gene encoding a sodium–potassium pump involved in development of hemiplegic migraine. In a research article published in JBC, scientists described a mutation in the ATP1A2 gene, which encodes the α2 subunit of sodium–potassium pump. Briefly, sodium potassium pump helps neurons in the brain transmit signals using a flow of Na+ and K+ ions. This study provides insights about the characteristics of ATP1A2 mutations and offers a new perspective for the development, diagnosis and treatment of migraine and other neurological disorders.

More neurobiology coverage

Ebola virus hides out in brain: Monkeys treated with monoclonal antibodies fully recovered, but infection recurred.

What indirectly links brain disease to COVID-19? Armin Bayati, a JBC Herbert Tabor Early Career Investigator Award winner, presented his lab’s research at the ASBMB annual meeting in April.

Brain Awareness Week: An overview of current areas of exploration in brain science and disease. Topics include Alzheimer's, stroke, multiple sclerosis, traumatic brain injury, addition and more.

Brain research highlights: A special edition of “From the Journals” featuring recent brain research published in the American Society for Biochemistry and Molecular Biology’s open-access journals.

Faulty immune response may be behind lingering brain trouble after COVID-19: Headaches and trouble thinking plague some people after a coronavirus infection.

Brain wrinkles and folds matter: Researchers are studying the mechanics of how they form.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Vaishnavi Muralikrishnan

Vaishnavi Muralikrishnan is a Ph.D. candidate at Indiana University. She studies ovarian cancer stem cells in the laboratory of Kenneth Nephew. She is passionate about science communication and enjoys her naps and drinking chai.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Researchers unravel mysteries of puzzling bacterial signals in our blood
Feature

Researchers unravel mysteries of puzzling bacterial signals in our blood

June 25, 2022

'Goldilocks phenomenon' could be good or bad, depending on a range of factors.

‘Molecular LEGO’ study analyzes building blocks of partially disordered protein
News

‘Molecular LEGO’ study analyzes building blocks of partially disordered protein

June 18, 2022

This method, detailed in PNAS, could affect a relatively young and exploding field of study.

Closing gaps to find new energy sources
News

Closing gaps to find new energy sources

June 15, 2022

Researchers implemented a new process to produce butanol, butanoic acid, hexanol and hexanoic acid.

Genetic mutations can be benign or cancerous
News

Genetic mutations can be benign or cancerous

June 12, 2022

A new method to differentiate between them could lead to better treatments.

Sex, immunity and the brain
Feature

Sex, immunity and the brain

June 11, 2022

Differences between the immune systems of males and females — in particular, ones involving cells called microglia — might help explain why the risk for conditions such as autism and Alzheimer’s varies between the sexes.

Novel eicosanoids from the COX-2 reaction: 5-hydroxy-prostaglandins
Lipid News

Novel eicosanoids from the COX-2 reaction: 5-hydroxy-prostaglandins

June 8, 2022

This biosynthetic pathway links lipoxygenase and cyclooxygenase enzymes.